Antonio Palumbo Joins Takeda
Takeda Pharmaceuticals International GMBH. has appointed Antonio Palumbo to the newly created role of distinguished research fellow oncology. Palumbo carries more than 26 years’ experience in hematology/oncology cancer research and previously was director, myeloma unit department hematology, University of Torino, Italy. He is currently a member of the Italian Society of Hematology, European Society for Medical Oncology, American Society of Hematology, and the American Society of Clinical Oncology.
You may also be interested in...
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.
The big winners of the night were AstraZeneca and Roche as pharma, biotech and allied industries came together online on 2 December to celebrate during a ceremony hosted by Ed Balls.